Differential Association of Protein Ser/Thr Phosphatase Types 1 and 2A with the Cytoskeleton upon Platelet Activation

Summary

The association of protein Ser/Thr phosphatase type 1(PP1) and type 2A (PP2A) with the cytoskeleton (Triton X-100 insoluble residue) during human platelet activation was investigated. In unstimulated platelets, 40% of total PPl-like activity was present in the Triton-insoluble cytoskeleton, while only 10% of the total PP2A-like activity was present in this fraction. Stimulation with 1 U/ml thrombin produced a 1.8-fold increase in PPl-like activity and a 7-fold increase in PP2A-like activity, respectively, in the cytoskeletal fraction, under aggregating conditions. Immunoblot analysis revealed that thrombin treatment increased association of PP1 catalytic subunit isozymes (PPlα, PPlβ, PP1γ) and PP2A catalytic subunit with the cytoskeleton, with concomitant decrease of these enzymes in Triton-soluble fractions. The amounts of cytoskeleton-associated PP1 and PP2A depended on the dose of thrombin which could activate platelets. Agonist-induced redistribution of PP1 and PP2A into the cytoskeleton was inhibited by OP-41483 (a prostaglandin I₂ analog). Interaction of PP2A with cytoskeletal proteins strongly correlates with aggregation, whereas the association of PP1 with cytoskeleton can be detected upon platelet activation, even in the absence of aggregation. Co-extraction of protein kinase C and myosin light chain kinase with the cytoskeleton eventually translocated to the cytoskeleton, but only during aggregation. These results suggest that differential translocation of PP1 and PP2A to the cytoskeleton is involved in platelet activation, and their association with cytoskeletal proteins may regulate phosphorylation levels together with protein kinases in platelets.

• References

• 1 Jennings LK, Fox JEB, Edwards HH, Phillips DR. Changes in the cytoskeletal structure of human platelets following thrombin activation. J Biol Chem 1981; 256: 6927-32
• 2 Carroll RC, Butler RG, Morris PA, Gerrard JM. Separable assembly of platelet pseudopodal and contractile cytoskeletons. Cell 1982; 30: 385-93
• 3 Kometani M, Sato T, Fujii T. Platelet cytoskeletal components involved in shape change and secretion. Thromb Res 1986; 41: 801-9
• 4 Kouns WC, Fox CF, Lamoreaux WJ, Coons LB, Jennings LK. The effect of gycoprotein Ilb-IIIa receptor occupancy on the cytoskeleton of resting and activated platelets. J Biol Chem 1991; 266: 13891-900
• 5 Daniel JL, Holmsen H, Adelstein RS. Thrombin-stimulated myosin phosphorylation in intact platelets and its possible involvement in secretion. Thromb Haemost 1977; 38: 984-9
• 6 Fox JEB, Phillips DR. Role of phosphorylation in mediating the association of myosin with the cytoskeletal structures of human platelets. J Biol Chem 1982; 257: 4120-6
• 7 Nishikawa M, Tanaka T, Hidaka H. Ca2+-calmodulin-dependent phosphorylation and platelet secretion. Nature 1980; 287: 863-5
• 8 Daniel JL, Molish IR, Rigmaiden M, Stewart G. Evidence for a role of myosin phosphorylation in the initiation ofthe platelet shape change response. J Biol Chem 1984; 259: 9826-31
• 9 Sellers JR. Regulation of cytoplasmic and smooth muscle myosin. Curr Biol 1991; 3: 98-104
• 10 Naka M, Nishikawa M, Adelstein RS, Hidaka H. Phorbol ester-induced activation of human platelets is associated with protein kinase C phosphorylation of myosin light chains. Nature 1983; 306: 490-2
• 11 Nishikawa M, Sellers JR, Adelstein RS, Hidaka H. Protein kinase C modulates in vitro phosphorylation of the smooth muscle heavy meromyosin by myosin light chain kinase. J Biol Chem 1984; 259: 8808-14
• 12 Ikebe M, Reardon S. Phosphorylation of bovine platelet myosin by protein kinase C. Biochemistry 1990; 29: 2713-20
• 13 Lamb NJC, Fernandez A, Conti MA, Adelstein RS, Glass DB, Welch WJ, Feramisco JR. Regulation of actin microfilament integrity in living nonmuscle cells by the cAMP-dependent protein kinase and the myosin light chain kinase. J Cell Biol 1988; 106: 1955-71
• 14 Lerea KM. Thrombin-induced effects are selectively inhibited following treatment of intact human platelets withokadaic acid. Biochemistry 1990; 30: 6819-24
• 15 Higashihara M, Takahata K, Kurokawa K, Ikebe M. The inhibitory effects of okadaic acid on platelet function. FEBS Lett 1992; 307: 206-10
• 16 Nishikawa M, Toyoda H, Saito M, Morita K, Tawara I, Deguchi K, Kuno T, Shima H, Nagao M, Shirakawa S. Calyculin A and okadaic acid inhibit human platelet aggregation byblocking protein phosphatases types1 and 2A. Cell. Signal. 1994; 6: 59-71
• 17 Cohen P. The structure and regulation ofprotein phosphatases. Annu Rev Biochem 1989; 58: 453-508
• 18 Mumby MC, Walter G. Protein serine/threonine phosphatases: Structure, regulation, and functions in cell growth. Physiol Rev 1993; 73: 673-99
• 19 Ozaki H, Ishihara H, Kohama K, Nonomura Y, Shibata S, Karaki H. Calcium-independent phosphorylation of smooth muscle myosin light chain by okadaic acid isolated fromblack sponge (Halichondria okadai). J Pharmacol Exp Ther 1987; 243: 1167-73
• 20 Ishihara H, Ozaki H, Sato K, Hori M, Karaki H, Watabe S, Kato Y, Fusetani N, Hashimoto K, Uemura D, Hartshome DJ. Calcium-independent activation of contractile apparatus in smooth muscle by calyculin-A. J Pharmacol Exp Ther 1989; 250: 388-96
• 21 Fernandez A, Brautigan DL, Mumby M, Lamb NJT. Protein phosphatase type-1, nottype-2A, modulates actin microfilament integrity and myosin light chain phosphorylation in living nonmuscle cells. J Cell Biol 1990; 111: 103-12
• 22 Chisholm AAK, Cohen P. The myosin-bound form of protein phosphatase 1 (PP-1M) is the enzyme that dephosphorylates native myosin in skeletal and cardiac muscle. Biochim Biophys Acta 1988; 971: 163-9
• 23 Haeberle GR, Hathaway DR, DePaoli-Roach AA. Dephosphorylation of myosin by the catalytic subunit of a type-2A phosphatase produces relaxation of chemically skinned uterine smooth muscle. J Biol Chem 1985; 260: 9965-8
• 24 Erdodi F, Rokolya A, Barany M, Barany K. Dephosphorylation ofdistinct sites in myosin light chain by two types of phosphatase in aortic smoothmuscle. Biochim Biophys Acta 1989; 1011: 67-74
• 25 Perrie WT, Perry SV. An electrophoretic study of thelow-molecular weight components of myosin. Biochem J 1970; 119: 31-8
• 26 Nishikawa M, Hidaka H. Role of calmodulin in platelet aggregation. Struc-ture-activity relationship of calmodulin antagonists. J Clin Invest 1982 69. 1348-1355
• 27 Fox JEB, Lipfert L, Clark EA, Reynolds CC, Austin CD, Brugge JS. On the role of the platelet membrane skeleton in mediating signal transduction. Association of GP Ilb-IIIa, pp60c src, pp62c yes, and the p21ras GTPase-ac-tivating protein with themembrane skeleton. J Biol Chem 1993 268. 25973-25984
• 28 Omay SB, Ogasawara H, Toyoda H, Nakai K, Shima H, Nagao M, Mumby MC, Shiku H, Nishikawa M. Translocation of protein phosphatase 1 catalytic subunits during 1,25-dihydroxy vitamin D3- induced monocytic differentiation of HL-60 cells. Cancer Res 1995; 55: 774-780
• 29 Pato MD, Kerc E. Purification and characterization of a smooth muscle myosin phosphatase from turkey gizzards. J Biol Chem 1985; 260: 12359-12366
• 30 Sasaki K, Shima H, Kitagawa Y, Irino S, Sugimura T, Nagao M. Identification of members of the protein phosphatase 1 gene familyin the rat and enhanced expression of protein phosphatase la gene in rat hepatocellular carcinoma. Jpn J Cancer Res 1990; 81: 1272-1280
• 31 Shima H, Hatano Y, Chun YS, Sugimura T, Zhang Z, Lee EYC, Nagao M. Identification of PP1 catalyticsubunit isotypes PPlyl, PP18 and PPla in various rat tissues. Biochem Biophys Res Commun 1993; 192: 1289-1296
• 32 Nishikawa M, de Lanerolle P, Linoln TM, Adelstein RS. Phosphorylation of mammalian myosin light chain kinases by the catalytic subunit of cyclic AMP-dependent protein kinase and by cyclic GMP-dependent protein kinase. J Biol Chem 1984; 259: 8429-8436
• 33 Bechtel PJ, Beavo JA, Krebs EG. Purification and characterization of catalytic subunit of skeletalmuscle adenosine 3’:5’-monophosphate-dependent protein kinase. J Biol Chem 1977; 252: 2691-2697
• 34 Fujitani B, Wakitani K. Studies on antiplatelet effects of OP-41483, a prostaglandin I2 analog, in experimental animals. II. Mechanism of its antiplatelet effect. Jap J Pharmacol 1990; 53: 25-33
• 35 Kouns WC, Kirchhofer D, Hadvary P, Edenhofer A, Weller T, Pfenninger G, Baumgartner HR, Jennings LK, Steiner B. Reversible conformational changes induced in glycoprotein Ilb-IIIaby a potent and selective peptido-mimetic inhibitor. Blood 1992; 80: 2539-2547
• 36 Graber SE, Hawiger J. Evidence that changes in platelet cyclic AMP levels regulate the fibrinogen receptor on human platelets. J Biol Chem 1982; 257: 14606-14609
• 37 Carroll RC, Gerrard JM. Phosphorylation of platelet actin-binding protein during platelet activation. Blood 1982; 59: 466-471
• 38 Sellers JR, Pato MD. Binding of smooth muscle myosinlight chain kinase and phosphatasesto actin and myosin. J Biol Chem 1984; 259: 7740-7746
• 39 Alessi D, Macdougall LK, Sola MM, Ikebe M, Cohen P. The control of protein phosphatase-1 by targetting subunits. The major myosin phosphatase in avian smooth muscle is a novel form of protein phosphatase-1. Eur J Biochem 1992 210. 1023-1035
• 40 Shimizu H, Ito M, Miyahara M, Ichikawa K, Okubo S, Konishi T, Naka M, Tanaka T, Hirano K, Hartshorne DJ, Nakano T. Characterization of the myosin-binding subunit of smooth muscle myosin phosphatase. J Biol Chem 1994; 269: 30407-30411
• 41 Beckerle MC, Yeh RK. Talin: Role at sites of cell-substratum adhesion. Cell Motility and Cytoskeleton 1990; 16: 7-13
• 42 Bertagnolli ME, Locke SJ, Hensler ME, Bray PF, Beckerle MC. Talin distribution and phosphorylation in thrombin-activated platelets. J Cell Sci 1993; 106: 1189-1199
• 43 Murata K, Sakon M, Kambayashi J, Okuyama M, Hase T, Mori T. Platelet talin is phosphorylated by calyculin A. J Cell Biochem 1993; 57: 120-126
• 44 Zhang J, Fry MJ, Waterfield MD, Jaken S, Liao L, Fox JEB, Rittenhouse SE. Activated phosphoinositide 3-kinase associates with membrane skeleton in thrombin-exposed platelets. J Biol Chem 1992; 267: 4686-4692
• 45 Shattil SJ, Brass LF. Induction of the fibrinogen receptor on human platelets by intracellular mediators. J Biol Chem 1987; 262: 992-1000